<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To test the hypothesis that the rare, often fatal, syndrome of <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:mpath ids='MPATH_58'>aplasia</z:mpath> is associated with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Case series </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Tertiary referral centers in the United States, Japan, Italy, and Germany </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS: Twenty-eight patients with <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> within 90 days after seeking medical attention for <z:hpo ids='HP_0000952'>jaundice</z:hpo>, or having serum transaminase levels 150% or more of <z:mpath ids='MPATH_458'>normal</z:mpath> (<z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:mpath ids='MPATH_58'>aplasia</z:mpath> patients) and three patients who developed <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> following liver transplantation for non-A, non-B <z:hpo ids='HP_0012115'>hepatitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>OUTCOME MEASURES: Presence of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C in serum, bone marrow, and liver samples, detected by the polymerase chain reaction; antibody testing; and percentage of activated peripheral cytotoxic T lymphocytes determined by immunophenotyping </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0012115'>Hepatitis</z:hpo> <z:chebi fb="3" ids="33697">ribonucleic acid</z:chebi> was present in the serum samples of 10 (36%) patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:mpath ids='MPATH_58'>aplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>However, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> was associated with transfusions received after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mpath ids='MPATH_58'>aplasia</z:mpath>: seven (58%) of 12 patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:mpath ids='MPATH_58'>aplasia</z:mpath> who had received 21 or more units of blood products at the time of serum sampling were viremic, compared with only three (19%) of 16 patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:mpath ids='MPATH_58'>aplasia</z:mpath> who had received 20 or less units of blood products (P less than .05) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0012115'>Hepatitis</z:hpo> C virus was not found in blood and bone marrow samples of three National Institutes of Health case patients tested at the time of diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>None of three livers from non-A, non-B <z:hpo ids='HP_0012115'>hepatitis</z:hpo> patients who developed <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> after liver transplantation contained <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus <z:chebi fb="3" ids="33697">ribonucleic acid</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Activated CD8+ T lymphocytes were elevated three- to 20-fold early in the course of <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:mpath ids='MPATH_58'>aplasia</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our results implicate a novel, non-A, non-B, and non-C agent in both <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:mpath ids='MPATH_58'>aplasia</z:mpath> and <z:hpo ids='HP_0004787'>fulminant hepatitis</z:hpo> </plain></SENT>
</text></document>